Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Horizon enrols first patient in Phase ll of Krystexxa and methotrexate

Gout present in the metatarsal-phalangeal joint of the big toe. Credit: James Heilman, MD.

Go Top